Pharmacological targeting of apelin impairs glioblastoma growth.
Pharmacological targeting of apelin impairs glioblastoma growth.
复制标题
DOI:
10.1093/brain/awx253
复制
发表时间:
2017-11-01
期刊:
影响因子:
--
通讯作者:
Gavard J
中科院分区:
文献类型:
--
作者:
Harford-Wright E;Andre-Gregoire G;Jacobs KA;Treps L;Le Gonidec S;Leclair HM;Gonzalez-Diest S;Roux Q;Guillonneau F;Loussouarn D;Oliver L;Vallette FM;Foufelle F;Valet P;Davenport AP;Glen RC;Bidere N;Gavard J
Glioblastomas are aggressive brain tumours that contain a subpopulation of highly plastic self-renewing cancer cells. Harford-Wright et al. show that the vasoactive peptide apelin, secreted by brain endothelial cells, regulates glioblastoma patient-derived cells with stem-like properties. Pharmacological blockade of apelin hampers glioblastoma cell expansion and improves survival in xenografted mice. Glioblastoma are highly aggressive brain tumours that are associated with an extremely poor prognosis. Within these tumours exists a subpopulation of highly plastic self-renewing cancer cells that retain the ability to expand ex vivo as tumourspheres, induce tumour growth in mice, and have been implicated in radio- and chemo-resistance. Although their identity and fate are regulated by external cues emanating from endothelial cells, the nature of such signals remains unknown. Here, we used a mass spectrometry proteomic approach to characterize the factors released by brain endothelial cells. We report the identification of the vasoactive peptide apelin as a central regulator for endothelial-mediated maintenance of glioblastoma patient-derived cells with stem-like properties. Genetic and pharmacological targeting of apelin cognate receptor abrogates apelin- and endothelial-mediated expansion of glioblastoma patient-derived cells with stem-like properties in vitro and suppresses tumour growth in vivo. Functionally, selective competitive antagonists of apelin receptor were shown to be safe and effective in reducing tumour expansion and lengthening the survival of intracranially xenografted mice. Therefore, the apelin/apelin receptor signalling nexus may operate as a paracrine signal that sustains tumour cell expansion and progression, suggesting that apelin is a druggable factor in glioblastoma.
登录
查看更多内容
影响因子:
3.7
作者:
Galan-Moya EM;Treps L;Oliver L;Chneiweiss H;Vallette FM;Bidère N;Gavard J
通讯作者:
Gavard J
影响因子:
24.5
作者:
Fournel, Audren;Drougard, Anne;Knauf, Claude
通讯作者:
Knauf, Claude
影响因子:
50.3
作者:
Cao Z;Scandura JM;Inghirami GG;Shido K;Ding BS;Rafii S
通讯作者:
Rafii S
影响因子:
64.8
作者:
Scimia, Maria Cecilia;Hurtado, Cecilia;Ray, Saugata;Metzler, Scott;Wei, Ke;Wang, Jianming;Woods, Chris E.;Purcell, Nicole H.;Catalucci, Daniele;Akasaka, Takeshi;Bueno, Orlando F.;Vlasuk, George P.;Kaliman, Perla;Bodmer, Rolf;Smith, Layton H.;Ashley, Euan;Mercola, Mark;Brown, Joan Heller;Ruiz-Lozano, Pilar
通讯作者:
Ruiz-Lozano, Pilar
影响因子:
11.2
作者:
Folkins, Chris;Man, Shan;Kerbel, Robert S.
通讯作者:
Kerbel, Robert S.